Clinical Trials Logo

Vision, Low clinical trials

View clinical trials related to Vision, Low.

Filter by:

NCT ID: NCT04391166 Completed - Visual Impairment Clinical Trials

Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic

Start date: May 20, 2020
Phase:
Study type: Observational

Prompted by the current COVID-19 pandemic, the American Academy of Ophthalmology has recommended the use of telemedicine to continue ophthalmic care while maintaining patient and provider social distancing. As part of remote examinations, patients may be expected to perform home eye testing for visual acuity and the use of various home visual acuity charts have been proposed to provide clinicians with this vital data. However, the use of home visual acuity exams has not been validated in our patient population. This project aims to determine the efficacy and validity of measuring visual acuity at home with a printed-out ETDRS chart.

NCT ID: NCT04249505 Completed - Astigmatism Clinical Trials

Refractive Accuracy of "2WIN" and Portable Autorefractors

Start date: January 9, 2020
Phase:
Study type: Observational

Youth and some adults have photoscreening refractions and hand-held auto refraction before cycloplegia refraction during new and follow up eye examinations. Vector math is applied to each refraction to determine how closely the hand-held "dry" devices match actual refraction.

NCT ID: NCT04242836 Completed - Presbyopia Clinical Trials

Development and Validation of a Digital Optotype for Near Vision in Greek Language.

DeDART
Start date: March 28, 2019
Phase:
Study type: Observational [Patient Registry]

Primary objective of our study is to develop and validate a computer-based digital near-vision optotype based on the Greek version of the print MNREAD.

NCT ID: NCT04237350 Completed - Visual Impairment Clinical Trials

Video Screening for Visual Impairment of Infants

Start date: January 14, 2020
Phase:
Study type: Observational

An individual senses the world and reflects feedbacks via independent behaviors. Such precise collaboration of the sensory and behavioral systems is fundamental to survival and evolution. When a sensory modality is altered, the behavioral system has the potential to fit in a substitute modality. However, the specific dynamics of human behaviors in response to sensory loss remain largely unknown due to the paucities of representative situations and large-scale samples. Here, the investigators focused on thousands of human infants who suffered varying degrees of visual stimuli deficiency in early stages, while their behavioral systems remained sensitive and thus retained high behavioral plasticity. Having access to this unique population provides an unprecedented opportunity to investigate the effect of diverse visual conditions on the behavioral system and develop a domestic apparatus for screening visual impariment of infants.

NCT ID: NCT04190147 Completed - Preterm Birth Clinical Trials

Eye and Growth in Adolescents Born Moderate-to-late Preterm

Start date: October 28, 2019
Phase:
Study type: Observational

During recent years, the interest in studying the risks of being born moderate-to-late preterm (MLP), defined as birth between gestational week 32 to 36, has increased. Today the investigators know that morbidity and mortality are significantly higher in these individuals compared to individuals born full-term. However, few studies have focused on the development of the eye in MLP individuals. The purpose of the study is to evaluate eye morphology and visual function in relation to growth, metabolism, blood pressure, neuropsychiatric factors, and quality of life in adolescents born MLP. The results of the examinations will be compared to an age-matched control group. The study will evaluate the structural, functional, and metabolic aspects of the eye with the hypothesis that early eye abnormalities may detect the risk of developing metabolic and cardiovascular diseases.

NCT ID: NCT04143620 Completed - Visual Impairment Clinical Trials

Triple Procedure for Dense Cataractus Neovascular Glaucoma Patients

NVG
Start date: July 1, 2016
Phase: N/A
Study type: Interventional

Background: One of the most difficult refractory glaucomas in treatment is the neovascular type and its association with dense cataract add to this difficulty. This study aimed to provide results of triple surgical treatment of such conditions. Methods: A total of 12 eyes of 12 patients with dense cataractus NVG patients were included in this study. The patients mean age was 57.25 ± 5.9 years. The mean pre-operative intraocular pressure (IOP) was 47.25 ± 4.04 mmHg with maximum antiglaucoma therapy. The mean best corrected distant visual acuities (BCDVA) in log MAR was 2.13 ± 0.38. All the patients received intra-vitreal injection of 1.25 mg (0.05 ml) bevacizumab followed by phacoemulsification, pars plana vitrectomy (PPV) including pan-retinal photocoagulation (PRP), and assisted trabeculectomy with Mitomycin c (MMC). Mean IOP and BCDVA changes were the main outcome results of this study.

NCT ID: NCT04143334 Completed - Cataract Clinical Trials

Prevalence of Blindness, Visual Impairment in Chao Nan Area, China

Start date: April 1, 2012
Phase:
Study type: Observational

This study will provide a profile of blindness/visual impairment, avoidable blindness and cataract surgery service in Chaonan, mainland China. We also evaluate the diagnostic accuracy of Rapid Assessment of Avoidable Blindness (RAAB) comparison with conventional survey.

NCT ID: NCT04127838 Completed - Parkinson Disease Clinical Trials

Low Vision Occupational Therapy in Parkinson's Disease

Start date: October 16, 2019
Phase: N/A
Study type: Interventional

The primary aim of this study is to determine whether low-vision occupational therapy improves quality of life in Parkinson's Disease (PD) patients. Low-vision occupational therapy has not been previously studied in PD patients, and we suspect that this is a beneficial treatment option for PD patients as vision impairment is common in the PD patient population. Our primary objective will assess whether quality of life was improved following a low-vision occupational therapy session.

NCT ID: NCT04074642 Completed - Pituitary Adenoma Clinical Trials

OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

FIRST
Start date: November 14, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to assess accurancy of OCT angiography as a pronostic marker for patients undergoing neurosurgery for compressiver macroadenoma as compared with visual acuity, visual field and OCT.

NCT ID: NCT04058067 Completed - Clinical trials for Diabetic Macular Edema

To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema

KINGLET
Start date: August 23, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of brolucizumab in treatment of Chinese patients with visual impairment due to Diabetic Macular Edema.